Alphabet-A
GOOGL
Alphabet-C
GOOG
MicroStrategy
MSTR
Tesla
TSLA
Ecopetrol
EC
US Stock MarketDetailed Quotes
VERA Vera Therapeutics
- 46.920
- -0.590-1.24%
Close Dec 10 16:00 ET
- 47.110
- +0.190+0.40%
Pre 08:25 ET
2.97BMarket Cap-17.98P/E (TTM)
48.490High46.760Low378.84KVolume47.750Open47.510Pre Close17.91MTurnover0.74%Turnover RatioLossP/E (Static)63.32MShares51.61052wk High10.28P/B2.42BFloat Cap14.20052wk Low--Dividend TTM51.51MShs Float51.610Historical High--Div YieldTTM3.64%Amplitude5.200Historical Low47.273Avg Price1Lot Size
About Vera Therapeutics Company
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
Company Profile
SymbolVERA
Company NameVera Therapeutics
Listing DateMay 14, 2021
Issue Price11.00
Founded2016
CEODr. Marshall Fordyce, M.D.
MarketNASDAQ
Employees51
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 1200
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-770-0077
Websitehttp://www.veratx.com
Company Executives
- Name
- Position
- Salary
- Dr. Marshall Fordyce, M.D.
- President, Chief Executive Officer and Director
- 3.43M
- Joseph Young
- Senior Vice President, Finance and Chief Accounting Officer
- --
- David L. Johnson, C.P.A.
- Chief Operating Officer
- --
- William D. Turner
- Chief Development Officer
- --
- Dr. Robert M. Brenner,M.D.
- Chief Medical Officer
- --
- Sean P. Grant
- Chief Financial Officer
- 1.76M
- Dr. Michael M. Morrissey, PhD
- Chairman of the Board
- 187.13K
- Christy J. Oliger
- Director
- --
- Dr. Andrew Cheng, M.D.,PhD
- Independent Director
- 154.63K
- Patrick G. Enright
- Independent Director
- 155.63K
- Kimball Hall
- Independent Director
- 152.04K
- Dr. Beth C. Seidenberg,M.D.
- Independent Director
- 153.13K
- Scott W. Morrison
- Independent Director
- 160.63K
- Dr. Maha Katabi, PhD
- Independent Director
- 153.63K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.